Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

547
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
547
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

2.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.6K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

852
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
852
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

433
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
433
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

753
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
753
Endotracheal Intubation I: Procedure01:15

Endotracheal Intubation I: Procedure

7.0K
Endotracheal or ET intubation is a critical medical procedure used to secure a patient's airway, often in acute respiratory distress, apnea, upper airway obstruction, ineffective clearance of secretions, high risk for aspiration, or during general anesthesia.
The ET tube comprises various components, including a standard adaptor to attach a bag-valve-mask (BVM) or ventilator, a cuff, a pilot balloon, and radiopaque markings along its length to measure the insertion distance. The tube sizes...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure.

Diabetes & vascular disease research·2026
Same author

The Rash That Will Not Go Away.

Clinical pediatrics·2026
Same author

Differential Outcomes With Empagliflozin and Dapagliflozin in Heart Failure With Mildly Reduced Ejection Fraction With and Without Diabetes Mellitus.

The American journal of cardiology·2026
Same author

Effectiveness of Nirmatrelvir/Ritonavir in Unvaccinated COVID-19 Patients Treated in the Emergency Department: A Retrospective Propensity-Matched Cohort Analysis.

Therapeutic advances in pulmonary and critical care medicine·2026
Same author

Differential Outcomes with Empagliflozin and Dapagliflozin in Heart Failure with Mildly Reduced Ejection Fraction.

medRxiv : the preprint server for health sciences·2026
Same author

Safety Planning for Youth in the Emergency Department Who Have Suicide Risk.

Journal of the American College of Emergency Physicians open·2025

Related Experiment Video

Updated: Jan 7, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.3K

Succinylcholine Versus Rocuronium for Pediatric Rapid Sequence Intubation in the Emergency Department.

Donna Mendez1, John Zatarain1, Krishna Paul1

  • 1Departments of Emergency Medicine.

Pediatric Emergency Care
|January 5, 2026
PubMed
Summary

In pediatric emergency medicine, succinylcholine use during rapid sequence intubation (RSI) was associated with lower mortality compared to rocuronium. This finding suggests succinylcholine may be a preferred agent for pediatric RSI in the ED.

Keywords:
Pediatric Emergency Medicinerapid sequence intubationrocuroniumsuccinylcholine

More Related Videos

An Improved Method for Rapid Intubation of the Trachea in Mice
08:46

An Improved Method for Rapid Intubation of the Trachea in Mice

Published on: February 22, 2016

26.2K
A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation
04:46

A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation

Published on: January 17, 2011

22.0K

Related Experiment Videos

Last Updated: Jan 7, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.3K
An Improved Method for Rapid Intubation of the Trachea in Mice
08:46

An Improved Method for Rapid Intubation of the Trachea in Mice

Published on: February 22, 2016

26.2K
A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation
04:46

A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation

Published on: January 17, 2011

22.0K

Area of Science:

  • Pediatric Emergency Medicine
  • Pharmacology
  • Critical Care

Background:

  • Neuromuscular blocking agents like succinylcholine and rocuronium are crucial for rapid sequence intubation (RSI) in emergency departments (ED).
  • Limited research exists comparing the safety and efficacy of these agents specifically in pediatric populations undergoing RSI.
  • Key outcomes of interest include mortality, post-traumatic stress disorder (PTSD), and malignant hyperthermia.

Purpose of the Study:

  • To compare the outcomes of death, PTSD, and malignant hyperthermia in children receiving succinylcholine versus rocuronium for RSI in the ED.
  • To identify potential differences in adverse events associated with these neuromuscular blocking agents in pediatric patients.

Main Methods:

  • A retrospective analysis of the TriNetX database was conducted, including pediatric patients (≤17 years) undergoing ED intubation between 2004 and 2024.
  • Patients received either succinylcholine or rocuronium as a paralytic agent, often in conjunction with etomidate or ketamine.
  • Propensity matching was employed to control for demographic and pre-existing condition differences between the two cohorts.

Main Results:

  • After propensity matching, 706 patients were analyzed in each cohort (succinylcholine vs. rocuronium).
  • Children receiving succinylcholine demonstrated a significantly lower mortality rate (5.7% vs. 8.9%, P=0.019).
  • No significant differences were observed in PTSD rates or malignant hyperthermia between the groups. Subgroup analysis indicated succinylcholine with etomidate as an optimal RSI drug combination.

Conclusions:

  • Succinylcholine administration was associated with reduced mortality in pediatric patients undergoing RSI in the ED compared to rocuronium.
  • The study suggests a potential benefit of succinylcholine for improving RSI outcomes in children.
  • Further prospective research is warranted to confirm these findings and guide clinical practice.